Authors:
GRUNEWALD M
MULLER M
ELLBRUCK D
OSTERHUES H
KOCHS M
MOHREN M
SCHIRMER G
ZIESCHE S
GULOGLU A
BOCK R
SEIFRIED E
Citation: M. Grunewald et al., DOUBLE-BOLUS VERSUS SINGLE-BOLUS THROMBOLYSIS WITH RETEPLASE FOR ACUTE-MYOCARDIAL-INFARCTION - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY, Fibrinolysis & proteolysis, 11(3), 1997, pp. 137-145
Authors:
FRICKHOFEN N
ELLBRUCK D
BIESTER I
JAINTA C
KOERNER K
WOLF H
SEIFREID E
Citation: N. Frickhofen et al., SIMILAR PREVALENCE OF HEPATITIS-C VIRUS-I NFECTION IN HEMOPHILIA PATIENTS TREATED IN 2 CLINICAL CENTERS IN THE FORMER WESTERN AND EASTERN PART OF GERMANY, Infusionstherapie und Transfusionsmedizin, 23(6), 1996, pp. 244-249
Citation: N. Frickhofen et al., INTERFERON THERAPY OF CHRONIC HEPATITIS-C IN HEMOPHILIACS, Deutsche Medizinische Wochenschrift, 120(5), 1995, pp. 157-157
Authors:
GRUNEWALD M
GRIESSHAMMER M
ELLBRUCK D
ZIMMERMANN R
SEIFRIED E
Citation: M. Grunewald et al., MONITORING OF HEMOSTATIC PARAMETERS DURING THROMBOLYSIS WITH RT-PA FOR DEEP VENOUS THROMBOSIS - CORRELATION WITH CLINICAL-RESULTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1326-1326
Authors:
GRUNEWALD M
ELLBRUCK D
MOHREN M
SCHIRMER G
OSTERHUES H
ZIESCHE S
GULOGLU A
BOCK R
SEIFRIED E
Citation: M. Grunewald et al., SINGLE VS DOUBLE BOLUS THROMBOLYSIS WITH THE RECOMBINANT PLASMINOGEN-ACTIVATOR BM-06.022 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION-PHARMACOKINETICS AND HEMOSTATIC CHANGES, Thrombosis and haemostasis, 73(6), 1995, pp. 1328-1328
Authors:
LIMMER J
ELLBRUCK D
MULLER H
EISELE E
RIST J
SCHUTZE F
BEGER H
HEIMPEL H
SEIFRIED E
Citation: J. Limmer et al., PROSPECTIVE RANDOMIZED CLINICAL-STUDY IN GENERAL-SURGERY COMPARING A NEW LOW-MOLECULAR-WEIGHT HEPARIN WITH UNFRACTIONATED HEPARIN IN THE PREVENTION OF THROMBOSIS, The Clinical investigator, 72(11), 1994, pp. 913-919